429 related articles for article (PubMed ID: 16034922)
21. Relaxation for perimenopausal and postmenopausal symptoms.
Saensak S; Vutyavanich T; Somboonporn W; Srisurapanont M
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD008582. PubMed ID: 25039019
[TBL] [Abstract][Full Text] [Related]
22. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
van de Weijer PH; Mattsson LA; Ylikorkala O
Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
[TBL] [Abstract][Full Text] [Related]
23. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.
Nelson HD
JAMA; 2004 Apr; 291(13):1610-20. PubMed ID: 15069049
[TBL] [Abstract][Full Text] [Related]
24. Oral oestrogen replacement therapy versus placebo for hot flushes.
MacLennan A; Lester S; Moore V
Cochrane Database Syst Rev; 2001; (1):CD002978. PubMed ID: 11279791
[TBL] [Abstract][Full Text] [Related]
25. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
[TBL] [Abstract][Full Text] [Related]
26. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
27. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.
Ismail SI; Bain C; Hagen S
Cochrane Database Syst Rev; 2010 Sep; (9):CD007063. PubMed ID: 20824855
[TBL] [Abstract][Full Text] [Related]
28. Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice.
Genazzani AR; Monteleone P; Giannini A; Simoncini T
Hum Reprod Update; 2021 Oct; 27(6):1115-1150. PubMed ID: 34432008
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy for cognitive function in postmenopausal women.
Hogervorst E; Yaffe K; Richards M; Huppert F
Cochrane Database Syst Rev; 2002; (3):CD003122. PubMed ID: 12137675
[TBL] [Abstract][Full Text] [Related]
30. Hormone therapy: a new consensus.
Harv Womens Health Watch; 2012 Oct; 20(2):8. PubMed ID: 23193635
[No Abstract] [Full Text] [Related]
31. Hormone replacement therapy to maintain cognitive function in women with dementia.
Hogervorst E; Yaffe K; Richards M; Huppert FA
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD003799. PubMed ID: 19160224
[TBL] [Abstract][Full Text] [Related]
32. Luteal phase support for assisted reproduction cycles.
van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
[TBL] [Abstract][Full Text] [Related]
33. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Gartlehner G; Patel SV; Feltner C; Weber RP; Long R; Mullican K; Boland E; Lux L; Viswanathan M
JAMA; 2017 Dec; 318(22):2234-2249. PubMed ID: 29234813
[TBL] [Abstract][Full Text] [Related]
34. Hormone replacement therapy to maintain cognitive function in women with dementia.
Hogervorst E; Yaffe K; Richards M; Huppert F
Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
[TBL] [Abstract][Full Text] [Related]
35. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
[TBL] [Abstract][Full Text] [Related]
36. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
Furness S; Roberts H; Marjoribanks J; Lethaby A; Hickey M; Farquhar C
Cochrane Database Syst Rev; 2009 Apr; (2):CD000402. PubMed ID: 19370558
[TBL] [Abstract][Full Text] [Related]
37. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
38. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
39. Phytoestrogens for vasomotor menopausal symptoms.
Lethaby AE; Brown J; Marjoribanks J; Kronenberg F; Roberts H; Eden J
Cochrane Database Syst Rev; 2007 Oct; (4):CD001395. PubMed ID: 17943751
[TBL] [Abstract][Full Text] [Related]
40. Oestrogen therapy for urinary incontinence in post-menopausal women.
Cody JD; Richardson K; Moehrer B; Hextall A; Glazener CM
Cochrane Database Syst Rev; 2009 Oct; (4):CD001405. PubMed ID: 19821277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
